Remy Luthringer - 22 Dec 2025 Form 4 Insider Report for Minerva Neurosciences, Inc. (NERV)

Role
CEO, Director
Signature
/s/ Geoff Race, Attorney-in-Fact
Issuer symbol
NERV
Transactions as of
22 Dec 2025
Net transactions value
$0
Form type
4
Filing time
23 Dec 2025, 16:15:09 UTC
Previous filing
06 Dec 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Luthringer Remy CEO, Director C/O MINERVA NEUROSCIENCES, INC., 1500 DISTRICT AVENUE, BURLINGTON /s/ Geoff Race, Attorney-in-Fact 23 Dec 2025 0001610384

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NERV Employee Stock Option (right to buy) Award $0 +2,250,000 $0.000000 2,250,000 22 Dec 2025 Common Stock 2,250,000 $3.98 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests 25% on December 22, 2026 and then in equal quarterly installments over 3 years thereafter.